Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant colorectal cancer chemotherapy study comparing bolus versus infusional 5-fluorouracil/leucovorin with nutritional and probiotic support randomization
ISRCTN98405441Phase 3Completed
- Sponsor
- Helsinki University Hospital
- Start
- Nov 1997
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluorouracil and folinic acid in colorectal cancer (CRC) (6 arms), sponsored by Helsinki University Hospital. Primary endpoints: Differences in toxicity profile, adverse events and quality of life between bolus and infusional treatment regimens, Cost-benefit differences between bolus and infusional treatment and 7 more. Started Nov 1997; status: completed.
02
Drugs
fluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ISRCTN98405441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN98405441.